ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Long-Acting Contraceptive Pills Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-8M18626
Home | Market Reports | Health| Reproductive Health
Global Long Acting Contraceptive Pills Market Research Report 2024
BUY CHAPTERS

Global Long-Acting Contraceptive Pills Market Research Report 2024

Code: QYRE-Auto-8M18626
Report
October 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Zhejiang Xianju Pharmaceutical
Pfizer Inc
Mylan NV
Teva Pharmaceuticals
Cipla Ltd
Bayer
Merck
Sun Pharma
Shanghai Pharmaceuticals

Long-Acting Contraceptive Pills Market Size

The global Long-Acting Contraceptive Pills market was valued at US$ 72.5 million in 2023 and is anticipated to reach US$ 150 million by 2030, witnessing a CAGR of 11.2% during the forecast period 2024-2030.

Long-Acting Contraceptive Pills Market

Long-Acting Contraceptive Pills Market

Long-acting contraceptives are medications or devices that provide sustained contraceptive effects with a single or periodic use. These contraceptives include injectables, subdermal implants, and intrauterine devices (IUDs), which can prevent pregnancy for months to years. They are designed to offer reliable, long-term contraception without the need for daily administration, making them suitable for women seeking extended protection against pregnancy.
North American market for Long-Acting Contraceptive Pills is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Long-Acting Contraceptive Pills is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Long-Acting Contraceptive Pills include Zhejiang Xianju Pharmaceutical, Pfizer, Mylan, Teva Pharmaceuticals, Cipla, Bayer, Merck, Sun Pharma, Shanghai Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Long-Acting Contraceptive Pills, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-Acting Contraceptive Pills.
The Long-Acting Contraceptive Pills market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Long-Acting Contraceptive Pills market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-Acting Contraceptive Pills manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Long-Acting Contraceptive Pills Market Report

Report Metric Details
Report Name Long-Acting Contraceptive Pills Market
Accounted market size in 2023 US$ 72.5 million
Forecasted market size in 2030 US$ 150 million
CAGR 11.2%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Injectables
  • Subdermal Implants
  • Intrauterine Devices
  • Other
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zhejiang Xianju Pharmaceutical, Pfizer, Mylan, Teva Pharmaceuticals, Cipla, Bayer, Merck, Sun Pharma, Shanghai Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Long-Acting Contraceptive Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Long-Acting Contraceptive Pills in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Long-Acting Contraceptive Pills Market growing?

Ans: The Long-Acting Contraceptive Pills Market witnessing a CAGR of 11.2% during the forecast period 2024-2030.

What is the Long-Acting Contraceptive Pills Market size in 2030?

Ans: The Long-Acting Contraceptive Pills Market size in 2030 will be US$ 150 million.

Who are the main players in the Long-Acting Contraceptive Pills Market report?

Ans: The main players in the Long-Acting Contraceptive Pills Market are Zhejiang Xianju Pharmaceutical, Pfizer, Mylan, Teva Pharmaceuticals, Cipla, Bayer, Merck, Sun Pharma, Shanghai Pharmaceuticals

What are the Application segmentation covered in the Long-Acting Contraceptive Pills Market report?

Ans: The Applications covered in the Long-Acting Contraceptive Pills Market report are Hospital, Clinic

What are the Type segmentation covered in the Long-Acting Contraceptive Pills Market report?

Ans: The Types covered in the Long-Acting Contraceptive Pills Market report are Injectables, Subdermal Implants, Intrauterine Devices, Other

Recommended Reports

Contraceptives & Implants

Long-Acting Pharmaceuticals

Pill Devices & Delivery

1 Long-Acting Contraceptive Pills Market Overview
1.1 Product Definition
1.2 Long-Acting Contraceptive Pills by Type
1.2.1 Global Long-Acting Contraceptive Pills Market Value Comparison by Type (2024-2030)
1.2.2 Injectables
1.2.3 Subdermal Implants
1.2.4 Intrauterine Devices
1.2.5 Other
1.3 Long-Acting Contraceptive Pills by Application
1.3.1 Global Long-Acting Contraceptive Pills Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Long-Acting Contraceptive Pills Market Size Estimates and Forecasts
1.4.1 Global Long-Acting Contraceptive Pills Revenue 2019-2030
1.4.2 Global Long-Acting Contraceptive Pills Sales 2019-2030
1.4.3 Global Long-Acting Contraceptive Pills Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Long-Acting Contraceptive Pills Market Competition by Manufacturers
2.1 Global Long-Acting Contraceptive Pills Sales Market Share by Manufacturers (2019-2024)
2.2 Global Long-Acting Contraceptive Pills Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Long-Acting Contraceptive Pills Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Long-Acting Contraceptive Pills, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Long-Acting Contraceptive Pills, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Long-Acting Contraceptive Pills, Product Type & Application
2.7 Global Key Manufacturers of Long-Acting Contraceptive Pills, Date of Enter into This Industry
2.8 Global Long-Acting Contraceptive Pills Market Competitive Situation and Trends
2.8.1 Global Long-Acting Contraceptive Pills Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Long-Acting Contraceptive Pills Players Market Share by Revenue
2.8.3 Global Long-Acting Contraceptive Pills Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Long-Acting Contraceptive Pills Market Scenario by Region
3.1 Global Long-Acting Contraceptive Pills Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Long-Acting Contraceptive Pills Sales by Region: 2019-2030
3.2.1 Global Long-Acting Contraceptive Pills Sales by Region: 2019-2024
3.2.2 Global Long-Acting Contraceptive Pills Sales by Region: 2025-2030
3.3 Global Long-Acting Contraceptive Pills Revenue by Region: 2019-2030
3.3.1 Global Long-Acting Contraceptive Pills Revenue by Region: 2019-2024
3.3.2 Global Long-Acting Contraceptive Pills Revenue by Region: 2025-2030
3.4 North America Long-Acting Contraceptive Pills Market Facts & Figures by Country
3.4.1 North America Long-Acting Contraceptive Pills Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Long-Acting Contraceptive Pills Sales by Country (2019-2030)
3.4.3 North America Long-Acting Contraceptive Pills Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Long-Acting Contraceptive Pills Market Facts & Figures by Country
3.5.1 Europe Long-Acting Contraceptive Pills Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Long-Acting Contraceptive Pills Sales by Country (2019-2030)
3.5.3 Europe Long-Acting Contraceptive Pills Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-Acting Contraceptive Pills Market Facts & Figures by Region
3.6.1 Asia Pacific Long-Acting Contraceptive Pills Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Long-Acting Contraceptive Pills Sales by Region (2019-2030)
3.6.3 Asia Pacific Long-Acting Contraceptive Pills Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Long-Acting Contraceptive Pills Market Facts & Figures by Country
3.7.1 Latin America Long-Acting Contraceptive Pills Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Long-Acting Contraceptive Pills Sales by Country (2019-2030)
3.7.3 Latin America Long-Acting Contraceptive Pills Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Long-Acting Contraceptive Pills Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-Acting Contraceptive Pills Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (2019-2030)
3.8.3 Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Long-Acting Contraceptive Pills Sales by Type (2019-2030)
4.1.1 Global Long-Acting Contraceptive Pills Sales by Type (2019-2024)
4.1.2 Global Long-Acting Contraceptive Pills Sales by Type (2025-2030)
4.1.3 Global Long-Acting Contraceptive Pills Sales Market Share by Type (2019-2030)
4.2 Global Long-Acting Contraceptive Pills Revenue by Type (2019-2030)
4.2.1 Global Long-Acting Contraceptive Pills Revenue by Type (2019-2024)
4.2.2 Global Long-Acting Contraceptive Pills Revenue by Type (2025-2030)
4.2.3 Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2019-2030)
4.3 Global Long-Acting Contraceptive Pills Price by Type (2019-2030)
5 Segment by Application
5.1 Global Long-Acting Contraceptive Pills Sales by Application (2019-2030)
5.1.1 Global Long-Acting Contraceptive Pills Sales by Application (2019-2024)
5.1.2 Global Long-Acting Contraceptive Pills Sales by Application (2025-2030)
5.1.3 Global Long-Acting Contraceptive Pills Sales Market Share by Application (2019-2030)
5.2 Global Long-Acting Contraceptive Pills Revenue by Application (2019-2030)
5.2.1 Global Long-Acting Contraceptive Pills Revenue by Application (2019-2024)
5.2.2 Global Long-Acting Contraceptive Pills Revenue by Application (2025-2030)
5.2.3 Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2019-2030)
5.3 Global Long-Acting Contraceptive Pills Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zhejiang Xianju Pharmaceutical
6.1.1 Zhejiang Xianju Pharmaceutical Company Information
6.1.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.1.3 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product Portfolio
6.1.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Long-Acting Contraceptive Pills Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Long-Acting Contraceptive Pills Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Company Information
6.4.2 Teva Pharmaceuticals Description and Business Overview
6.4.3 Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
6.4.5 Teva Pharmaceuticals Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cipla Long-Acting Contraceptive Pills Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Company Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bayer Long-Acting Contraceptive Pills Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Merck
6.7.1 Merck Company Information
6.7.2 Merck Description and Business Overview
6.7.3 Merck Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Merck Long-Acting Contraceptive Pills Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Sun Pharma
6.8.1 Sun Pharma Company Information
6.8.2 Sun Pharma Description and Business Overview
6.8.3 Sun Pharma Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sun Pharma Long-Acting Contraceptive Pills Product Portfolio
6.8.5 Sun Pharma Recent Developments/Updates
6.9 Shanghai Pharmaceuticals
6.9.1 Shanghai Pharmaceuticals Company Information
6.9.2 Shanghai Pharmaceuticals Description and Business Overview
6.9.3 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
6.9.5 Shanghai Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-Acting Contraceptive Pills Industry Chain Analysis
7.2 Long-Acting Contraceptive Pills Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-Acting Contraceptive Pills Production Mode & Process
7.4 Long-Acting Contraceptive Pills Sales and Marketing
7.4.1 Long-Acting Contraceptive Pills Sales Channels
7.4.2 Long-Acting Contraceptive Pills Distributors
7.5 Long-Acting Contraceptive Pills Customers
8 Long-Acting Contraceptive Pills Market Dynamics
8.1 Long-Acting Contraceptive Pills Industry Trends
8.2 Long-Acting Contraceptive Pills Market Drivers
8.3 Long-Acting Contraceptive Pills Market Challenges
8.4 Long-Acting Contraceptive Pills Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Zhejiang Xianju Pharmaceutical
Pfizer Inc
Mylan NV
Teva Pharmaceuticals
Cipla Ltd
Bayer
Merck
Sun Pharma
Shanghai Pharmaceuticals
List of Tables
 Table 1. Global Long-Acting Contraceptive Pills Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Long-Acting Contraceptive Pills Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Long-Acting Contraceptive Pills Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Long-Acting Contraceptive Pills Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Long-Acting Contraceptive Pills Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Long-Acting Contraceptive Pills Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Long-Acting Contraceptive Pills Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Long-Acting Contraceptive Pills, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Long-Acting Contraceptive Pills, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Long-Acting Contraceptive Pills, Product Type & Application
 Table 12. Global Key Manufacturers of Long-Acting Contraceptive Pills, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Long-Acting Contraceptive Pills by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Contraceptive Pills as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Long-Acting Contraceptive Pills Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Long-Acting Contraceptive Pills Sales by Region (2019-2024) & (K Units)
 Table 18. Global Long-Acting Contraceptive Pills Sales Market Share by Region (2019-2024)
 Table 19. Global Long-Acting Contraceptive Pills Sales by Region (2025-2030) & (K Units)
 Table 20. Global Long-Acting Contraceptive Pills Sales Market Share by Region (2025-2030)
 Table 21. Global Long-Acting Contraceptive Pills Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Long-Acting Contraceptive Pills Revenue Market Share by Region (2019-2024)
 Table 23. Global Long-Acting Contraceptive Pills Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Long-Acting Contraceptive Pills Revenue Market Share by Region (2025-2030)
 Table 25. North America Long-Acting Contraceptive Pills Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Long-Acting Contraceptive Pills Sales by Country (2019-2024) & (K Units)
 Table 27. North America Long-Acting Contraceptive Pills Sales by Country (2025-2030) & (K Units)
 Table 28. North America Long-Acting Contraceptive Pills Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Long-Acting Contraceptive Pills Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Long-Acting Contraceptive Pills Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Long-Acting Contraceptive Pills Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Long-Acting Contraceptive Pills Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Long-Acting Contraceptive Pills Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Long-Acting Contraceptive Pills Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Long-Acting Contraceptive Pills Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Long-Acting Contraceptive Pills Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Long-Acting Contraceptive Pills Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Long-Acting Contraceptive Pills Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Long-Acting Contraceptive Pills Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Long-Acting Contraceptive Pills Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Long-Acting Contraceptive Pills Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Long-Acting Contraceptive Pills Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Long-Acting Contraceptive Pills Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Long-Acting Contraceptive Pills Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Long-Acting Contraceptive Pills Sales (K Units) by Type (2019-2024)
 Table 51. Global Long-Acting Contraceptive Pills Sales (K Units) by Type (2025-2030)
 Table 52. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2019-2024)
 Table 53. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2025-2030)
 Table 54. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2019-2024)
 Table 57. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2025-2030)
 Table 58. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Long-Acting Contraceptive Pills Sales (K Units) by Application (2019-2024)
 Table 61. Global Long-Acting Contraceptive Pills Sales (K Units) by Application (2025-2030)
 Table 62. Global Long-Acting Contraceptive Pills Sales Market Share by Application (2019-2024)
 Table 63. Global Long-Acting Contraceptive Pills Sales Market Share by Application (2025-2030)
 Table 64. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2019-2024)
 Table 67. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2025-2030)
 Table 68. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Application (2025-2030)
 Table 70. Zhejiang Xianju Pharmaceutical Company Information
 Table 71. Zhejiang Xianju Pharmaceutical Description and Business Overview
 Table 72. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product
 Table 74. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Pfizer Long-Acting Contraceptive Pills Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Mylan Company Information
 Table 81. Mylan Description and Business Overview
 Table 82. Mylan Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Mylan Long-Acting Contraceptive Pills Product
 Table 84. Mylan Recent Developments/Updates
 Table 85. Teva Pharmaceuticals Company Information
 Table 86. Teva Pharmaceuticals Description and Business Overview
 Table 87. Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Teva Pharmaceuticals Long-Acting Contraceptive Pills Product
 Table 89. Teva Pharmaceuticals Recent Developments/Updates
 Table 90. Cipla Company Information
 Table 91. Cipla Description and Business Overview
 Table 92. Cipla Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Cipla Long-Acting Contraceptive Pills Product
 Table 94. Cipla Recent Developments/Updates
 Table 95. Bayer Company Information
 Table 96. Bayer Description and Business Overview
 Table 97. Bayer Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Bayer Long-Acting Contraceptive Pills Product
 Table 99. Bayer Recent Developments/Updates
 Table 100. Merck Company Information
 Table 101. Merck Description and Business Overview
 Table 102. Merck Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Merck Long-Acting Contraceptive Pills Product
 Table 104. Merck Recent Developments/Updates
 Table 105. Sun Pharma Company Information
 Table 106. Sun Pharma Description and Business Overview
 Table 107. Sun Pharma Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Sun Pharma Long-Acting Contraceptive Pills Product
 Table 109. Sun Pharma Recent Developments/Updates
 Table 110. Shanghai Pharmaceuticals Company Information
 Table 111. Shanghai Pharmaceuticals Description and Business Overview
 Table 112. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product
 Table 114. Shanghai Pharmaceuticals Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Long-Acting Contraceptive Pills Distributors List
 Table 118. Long-Acting Contraceptive Pills Customers List
 Table 119. Long-Acting Contraceptive Pills Market Trends
 Table 120. Long-Acting Contraceptive Pills Market Drivers
 Table 121. Long-Acting Contraceptive Pills Market Challenges
 Table 122. Long-Acting Contraceptive Pills Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Long-Acting Contraceptive Pills
 Figure 2. Global Long-Acting Contraceptive Pills Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Long-Acting Contraceptive Pills Market Share by Type: 2023 & 2030
 Figure 4. Injectables Product Picture
 Figure 5. Subdermal Implants Product Picture
 Figure 6. Intrauterine Devices Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Long-Acting Contraceptive Pills Market Value by Application (2024-2030) & (US$ Million)
 Figure 9. Global Long-Acting Contraceptive Pills Market Share by Application: 2023 & 2030
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Global Long-Acting Contraceptive Pills Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Long-Acting Contraceptive Pills Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Long-Acting Contraceptive Pills Sales (2019-2030) & (K Units)
 Figure 15. Global Long-Acting Contraceptive Pills Average Price (US$/Unit) & (2019-2030)
 Figure 16. Long-Acting Contraceptive Pills Report Years Considered
 Figure 17. Long-Acting Contraceptive Pills Sales Share by Manufacturers in 2023
 Figure 18. Global Long-Acting Contraceptive Pills Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Long-Acting Contraceptive Pills Players: Market Share by Revenue in Long-Acting Contraceptive Pills in 2023
 Figure 20. Long-Acting Contraceptive Pills Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Long-Acting Contraceptive Pills Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Long-Acting Contraceptive Pills Sales Market Share by Country (2019-2030)
 Figure 23. North America Long-Acting Contraceptive Pills Revenue Market Share by Country (2019-2030)
 Figure 24. United States Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Long-Acting Contraceptive Pills Sales Market Share by Country (2019-2030)
 Figure 27. Europe Long-Acting Contraceptive Pills Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Long-Acting Contraceptive Pills Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Long-Acting Contraceptive Pills Revenue Market Share by Region (2019-2030)
 Figure 35. China Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Long-Acting Contraceptive Pills Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Long-Acting Contraceptive Pills Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Long-Acting Contraceptive Pills Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Long-Acting Contraceptive Pills Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Long-Acting Contraceptive Pills by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Long-Acting Contraceptive Pills by Type (2019-2030)
 Figure 54. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Long-Acting Contraceptive Pills by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Long-Acting Contraceptive Pills by Application (2019-2030)
 Figure 57. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Application (2019-2030)
 Figure 58. Long-Acting Contraceptive Pills Value Chain
 Figure 59. Long-Acting Contraceptive Pills Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Long acting and Short acting Oral Contraceptives Market Research Report 2025
Intrauterine Contraceptive Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gynecological Contraceptive Implant Market Research Report 2024
Intra Uterine Contraceptive Devices Market
Global Implantable Contraceptive Drug Eluting Devices Market Research Report 2024
Global Contraceptive Drug Eluting Devices Market Research Report 2024
Global Long acting Contraceptive Injection Market Research Report 2024
Global Contraceptives Devices Market Insights Forecast to 2030
Global Long Acting Reversible Contraception LARC Market Research Report 2024
Contraceptive Implants Market
Global Contraceptives Drugs Market Insights Forecast to 2030
Intrauterine Contraceptive Ring Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Contraceptives Drugs and Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Contraceptive Devices Market Research Report 2024
Global Oral Contraceptive Drugs Market Insights Forecast to 2030
Global Subdermal Contraceptive Implants Market Insights Forecast to 2030
Contraceptive Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Levonorgestrel Market Insights Forecast to 2030
Contraceptive Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intrauterine Contraceptive Devices IUCD Market Insights Forecast to 2030

RELATED REPORTS

Global Microfluidic in Vitro Diagnostics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z19487
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Yohimbe Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34B2983
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Erection Rings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19V3238
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Sperm Bank Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35F5845
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions